Trial Information

Summary: Low Back Pain? Are you 18 or older? If so, University Clinical Research may have an option for you!

  • The study consists of 16 weeks of study, 10 outpatient only visits and study patch or medication.
  • Laboratory testing and study medication is provided at no cost to the participating patients.
  • Financial compensation at the end of the study may be up to $280.00
  • Placebo may be included
  • Study will be closing soon! Limited spacing available!

Study Criteria:

  • Must be 18 or older.
  • Back pain can not be caused due to injury or car accident in the recent 2-3 years(exceptions are available)
  • No Fibromyalgia
  • No uncontrolled seizures
  • No antidepressants being used as pain agents
  • Must speak English
  • Must pass screening

For more information,

Contact:

Carla and Carolina, Patient Recruiters
University Clinical Research, Inc.
1150 N. University Drive
Pembroke Pines, FL 33024
Telephone: 954-437-5988 ext 207
Fax: 954-432-6255
Email:

Profile Page: University Clinical Research, Inc., Pembroke Pines, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:41 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA